{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:58:16Z","timestamp":1792803496480,"version":"4.5.0"},"reference-count":85,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T00:00:00Z","timestamp":1549324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Ministry of Health, Labor and Welfare of Japan and the Ministry of Education, Culture, Sports, Science and Technology of Japan","award":["H29-022 and 17K09777"],"award-info":[{"award-number":["H29-022 and 17K09777"]}],"id":[{"id":"https:\/\/ror.org\/048rj2z13","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has traditionally been termed senile systemic amyloidosis, while ATTRv amyloidosis has been called familial amyloid polyneuropathy. Although ATTRwt amyloidosis has classically been regarded as one of the causes of cardiomyopathy occurring in the elderly population, recent developments in diagnostic techniques have significantly expanded the concept of this disease. For example, this disease is now considered an important cause of carpal tunnel syndrome in the elderly population. The phenotypes of ATTRv amyloidosis also vary depending on the mutation and age of onset. Peripheral neuropathy usually predominates in patients from the conventional endemic foci, while cardiomyopathy or oculoleptomeningeal involvement may also become major problems in other patients. Electron microscopic studies indicate that the direct impact of amyloid fibrils on surrounding tissues leads to organ damage, whereas accumulating evidence suggests that nonfibrillar TTR, such as oligomeric TTR, is toxic, inducing neurodegeneration. Microangiopathy has been suggested to act as an initial lesion, increasing the leakage of circulating TTR. Regarding treatments, the efficacy of liver transplantation has been established for ATTRv amyloidosis patients, particularly patients with early-onset amyloidosis. Recent phase III clinical trials have shown the efficacy of TTR stabilizers, such as tafamidis and diflunisal, for both ATTRwt and ATTRv amyloidosis patients. In addition, a short interfering RNA (siRNA), patisiran, and an antisense oligonucleotide (ASO), inotersen, have been shown to be effective for ATTRv amyloidosis patients. Given their ability to significantly reduce the production of both wild-type and variant TTR in the liver, these gene-silencing drugs seem to be the optimal therapeutic option for ATTR amyloidosis. Hence, the long-term efficacy and tolerability of novel therapies, particularly siRNA and ASO, must be determined to establish an appropriate treatment program.<\/jats:p>","DOI":"10.3390\/biomedicines7010011","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T03:03:05Z","timestamp":1549422185000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights"],"prefix":"10.3390","volume":"7","author":[{"given":"Haruki","family":"Koike","sequence":"first","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9311","authenticated-orcid":false,"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,2,5]]},"reference":[{"key":"ref_1","first-page":"391","article-title":"Senile systemic amyloidosis","volume":"117","author":"Westermark","year":"1984","journal-title":"Am. J. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.59.11.1771","article-title":"Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: Early- vs. late-onset form","volume":"59","author":"Koike","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/mus.20821","article-title":"The molecular biology and clinical features of amyloid neuropathy","volume":"36","author":"Benson","year":"2007","journal-title":"Muscle Nerve"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Said","year":"2011","journal-title":"Lancet Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/WCO.0000000000000476","article-title":"Familial amyloid polyneuropathy","volume":"30","author":"Adams","year":"2017","journal-title":"Curr. Opin. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/brain\/75.3.408","article-title":"A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves","volume":"75","author":"Andrade","year":"1952","journal-title":"Brain"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1001\/archneur.1968.00470360015001","article-title":"Polyneuritic amyloidosis in a Japanese family","volume":"18","author":"Araki","year":"1968","journal-title":"Arch. Neurol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.0954-6820.1970.tb08009.x","article-title":"Hereditary amyloidosis with polyneuropathy","volume":"1\u20132","author":"Andersson","year":"1970","journal-title":"Acta Med. Scand."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/archneur.62.7.1057","article-title":"Transthyretin-related familial amyloidotic polyneuropathy","volume":"62","author":"Ando","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1136\/jnnp-2011-301299","article-title":"Natural history of transthyretin Val30Met familial amyloid polyneuropathy: Analysis of late-onset cases from non-endemic areas","volume":"83","author":"Koike","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/WCO.0000000000000288","article-title":"European Network for TTR-FAP (ATTReuNET). Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: Where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP","volume":"29","author":"Parman","year":"2016","journal-title":"Curr. Opin. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13023-017-0726-x","article-title":"Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: Red-flag symptom clusters and treatment algorithm","volume":"13","author":"Sekijima","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.24438","article-title":"Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates","volume":"78","author":"Chao","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/jnnp-2015-310907","article-title":"A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK","volume":"87","author":"Carr","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nmd.2016.04.013","article-title":"Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey","volume":"26","author":"Matur","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1399-0004.1991.tb03085.x","article-title":"Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30)","volume":"40","author":"Holmgren","year":"1991","journal-title":"Clin. Genet."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1212\/WNL.0b013e318248df18","article-title":"Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy","volume":"78","author":"Yamashita","year":"2012","journal-title":"Neurology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-2836(74)90291-5","article-title":"Structure of human plasma prealbumin at 2\u20135 A resolution. a preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding","volume":"88","author":"Blake","year":"1974","journal-title":"J. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0006-291X(85)80027-9","article-title":"High prealbumin and transferrin mRNA levels in the choroid plexus of rat brain","volume":"127","author":"Dickson","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11793","DOI":"10.1016\/S0021-9258(17)39100-7","article-title":"Demonstration of transthyretin mRNA in the brain and other extrahepatic tissues in the rat","volume":"260","author":"Soprano","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1001\/archneur.56.9.1152","article-title":"Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64","volume":"56","author":"Uemichi","year":"1999","journal-title":"Arch. Neurol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/endo-63-2-256","article-title":"Pre-albumin: A thyroxinebinding protein of human plasma","volume":"63","author":"Ingbar","year":"1958","journal-title":"Endocrinology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","article-title":"The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex","volume":"244","author":"Raz","year":"1969","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0969-2126(97)00215-3","article-title":"Amyloid fibril formation and protein misassembly: A structural quest for insights into amyloid and prion diseases","volume":"5","author":"Kelly","year":"1997","journal-title":"Structure"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1073\/pnas.87.7.2843","article-title":"Fibril in senile systemic amyloidosis is derived from normal transthyretin","volume":"87","author":"Westermark","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/joim.12585","article-title":"One mutation, two distinct disease variants: Unravelling the impact of transthyretin amyloid fibril composition","volume":"281","author":"Suhr","year":"2017","journal-title":"J. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"14192","DOI":"10.1074\/jbc.RA118.003990","article-title":"Plasminogen activation triggers transthyretin amyloidogenesis in vitro","volume":"293","author":"Mangione","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000132966.36437.12","article-title":"Pathology of early- vs. late-onset TTR Met30 familial amyloid polyneuropathy","volume":"63","author":"Koike","year":"2004","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation","volume":"75","author":"Cornwell","year":"1983","journal-title":"Am. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in \u03b12-macroglobulin and tau: A population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/modpathol.2011.117","article-title":"Clinicopathological features of senile systemic amyloidosis: An ante- and post-mortem study","volume":"24","author":"Ueda","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/13506129.2017.1409706","article-title":"First nationwide survey on systemic wild-type ATTR amyloidosis in Japan","volume":"25","author":"Sekijima","year":"2018","journal-title":"Amyloid"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/03009734.2014.895786","article-title":"Transthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis","volume":"119","author":"Westermark","year":"2014","journal-title":"Ups J. Med. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/modpathol.2014.102","article-title":"Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis","volume":"28","author":"Yanagisawa","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1007\/s00415-008-0962-z","article-title":"Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci","volume":"255","author":"Koike","year":"2008","journal-title":"J. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/13506120903094074","article-title":"The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy","volume":"16","author":"Koike","year":"2009","journal-title":"Amyloid"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00415-017-8640-7","article-title":"Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: Experience from a single-referral center in Japan","volume":"265","author":"Yamashita","year":"2018","journal-title":"J. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1517\/17530059.2010.495384","article-title":"Diagnosis of familial amyloid polyneuropathy: Wide-ranged clinicopathological features","volume":"4","author":"Koike","year":"2010","journal-title":"Expert Opin. Med. Diagn."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/13506129.2012.674580","article-title":"Late-onset familial amyloid polyneuropathy in Japan","volume":"19","author":"Koike","year":"2012","journal-title":"Amyloid"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1136\/jnnp-2013-305383","article-title":"Overcoming artefact: Anticipation in 284 Portuguese kindreds with familial amyloid polyneuropathy (FAP) ATTRV30M","volume":"85","author":"Lemos","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/13506129.2011.565524","article-title":"Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: A practical analysis","volume":"18","author":"Koike","year":"2011","journal-title":"Amyloid"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/brain\/122.10.1951","article-title":"Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features","volume":"122","author":"Misu","year":"1999","journal-title":"Brain"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1212\/WNL.55.3.451-a","article-title":"Anticipation in early- but not late-onset familial amyloid polyneuropathy (TTR met 30) in Japan","volume":"55","author":"Misu","year":"2000","journal-title":"Neurology"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1212\/WNL.0000000000003362","article-title":"Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy","volume":"87","author":"Koike","year":"2016","journal-title":"Neurology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Robles","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/path.2411","article-title":"Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis","volume":"216","author":"Ihse","year":"2008","journal-title":"J. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/13506129.2013.797890","article-title":"Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis","volume":"20","author":"Ihse","year":"2013","journal-title":"Amyloid"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jns.2009.07.028","article-title":"Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy","volume":"287","author":"Koike","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jns.2018.09.011","article-title":"The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study","volume":"394","author":"Koike","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/path.1759","article-title":"Amyloid deposits in transthyretin-derived amyloidosis: Cleaved transthyretin is associated with distinct amyloid morphology","volume":"206","author":"Gustavsson","year":"2005","journal-title":"J. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1600-6143.2006.01585.x","article-title":"Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients","volume":"7","author":"Yazaki","year":"2007","journal-title":"Am. J. Transplant."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/lt.21817","article-title":"Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients\u2019 survival","volume":"15","author":"Okamoto","year":"2009","journal-title":"Liver Transplant."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jnnp-2013-305973","article-title":"Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation","volume":"85","author":"Oshima","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15252\/emmm.201505357","article-title":"A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis","volume":"7","author":"Marcoux","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.humpath.2010.11.017","article-title":"Wild-type transthyretin-derived amyloidosis in various ligaments and tendons","volume":"42","author":"Sueyoshi","year":"2011","journal-title":"Hum. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/path.2618","article-title":"Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy","volume":"219","author":"Misumi","year":"2009","journal-title":"J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11618","DOI":"10.1021\/bi050700m","article-title":"Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity","volume":"44","author":"Hou","year":"2005","journal-title":"Biochemistry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1111\/febs.14587","article-title":"Crucial role of protein oligomerization in the pathogenesis of Alzheimer\u2019s and Parkinson\u2019s diseases","volume":"285","author":"Choi","year":"2018","journal-title":"FEBS J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"E7710","DOI":"10.1073\/pnas.1801117115","article-title":"Cellular clearance of circulating transthyretin decreases cell-nonautonomous proteotoxicity in Caenorhabditis elegans","volume":"115","author":"Madhivanan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0002-9440(10)63050-7","article-title":"Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: Evidence for toxicity of nonfibrillar aggregates","volume":"159","author":"Sousa","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1471-4159.2006.03716.x","article-title":"Activation of ERK1\/2 MAP kinases in familial amyloidotic polyneuropathy","volume":"97","author":"Monteiro","year":"2006","journal-title":"J. Neurochem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neuro.2013.08.013","article-title":"Pro-oxidative effects of aggregated transthyretin in human Schwannoma cells","volume":"39","author":"Fong","year":"2013","journal-title":"Neurotoxicology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1016\/S0002-9440(10)64469-0","article-title":"Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro","volume":"161","author":"Sousa","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.bbrc.2006.11.045","article-title":"A transgenic rat with the human ATTR V30M: A novel tool for analyses of ATTR metabolisms","volume":"352","author":"Ueda","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin Cardiac Amyloidosis","volume":"70","author":"Treibel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ajo.2018.05.023","article-title":"Angiographic signatures of the predominant form of familial transthyretin amyloidosis (Val30Met Mutation)","volume":"192","author":"Rousseau","year":"2018","journal-title":"Am. J. Ophthalmol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0046-8177(91)90227-G","article-title":"Familial amyloidotic polyneuropathy type 1 in Kumamoto, Japan: A clinicopathologic, histochemical, immunohistochemical, and ultrastructural study","volume":"22","author":"Takahashi","year":"1991","journal-title":"Hum. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jns.2009.05.001","article-title":"Familial amyloid polyneuropathy: A clinico-pathologic study","volume":"284","author":"Said","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1212\/WNL.0000000000004178","article-title":"Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs. clinicopathologic tools","volume":"89","author":"Kollmer","year":"2017","journal-title":"Neurology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"31752","DOI":"10.1074\/jbc.M113.469858","article-title":"Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells","volume":"288","author":"Nunes","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1159\/000481562","article-title":"Transthyretin exerts pro-apoptotic effects in human retinal microvascular endothelial cells through a GRP78-dependent pathway in diabetic retinopathy","volume":"43","author":"Shao","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"ref_79","first-page":"185","article-title":"Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4","volume":"23","author":"Du","year":"2017","journal-title":"Mol. Vis."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"25096","DOI":"10.1074\/jbc.M116.738138","article-title":"Novel Antibody for the Treatment of Transthyretin Amyloidosis","volume":"291","author":"Hosoi","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1212\/WNL.0b013e3181ea15d4","article-title":"Progression of transthyretin amyloid neuropathy after liver transplantation","volume":"75","author":"Liepnieks","year":"2010","journal-title":"Neurology"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mus.23480","article-title":"Impact of aging on the progression of neuropathy after liver transplantation in transthyretin Val30Met amyloidosis","volume":"46","author":"Koike","year":"2012","journal-title":"Muscle Nerve"},{"key":"ref_83","first-page":"6319","article-title":"Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: An observational study","volume":"9","author":"Bauer","year":"2015","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10741-015-9480-0","article-title":"Cardiac amyloidosis: The great pretender","volume":"20","author":"Rapezzi","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.34.8.1025","article-title":"Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: A clinicopathologic study","volume":"34","author":"Said","year":"1984","journal-title":"Neurology"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/7\/1\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:31:08Z","timestamp":1760185868000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/7\/1\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,5]]},"references-count":85,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["biomedicines7010011"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines7010011","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,5]]}}}